Metafora Biosystems
is a biotechnology company that develops diagnostic tests to detect abnormalities in cellular energetics... Read moreMetafora Biosystems
is a biotechnology company that develops diagnostic tests to detect abnormalities in cellular energetics... Read more
News
May 03, 2023
Business Wire
Press Release: Metafora Biosystems : METAFORA's Test for the Early Diagnosis of De Vivo Disease Recommended for Coverage by HAS
Jan 30, 2023
FinanzNachrichten
Metafora Biosystems: METAFORA biosystems: METAFORA Launches METAflow, its Digital Cytometry Analysis Platform
Dec 12, 2022
Acrofan
Metafora Biosystems: METAFORA partner Wugen to Present Data Supporting Clinical Development of WU-NK-101 for Relapsed / Refractory AML at the American Society of Hematolog
Jun 02, 2022
FinanzNachrichten
Metafora Biosystems: METAFORA launches METAflow, a first-in-kind digital cytometry analysis platform
Sep 21, 2021
BioSpace
Metafora Biosystems: Sebia and Metafora biosystems form Strategic partnership to Develop Advanced In Vitro Diagnostics tests
Mar 12, 2019
BioSpace
Metafora: Metafora Biosystems receives €1M innovation challenge grant from Bpifrance
Oct 17, 2018
Metafora Biosystems Youtube Channel
Metafora Biosystems posted a video "METAglut1, pour le diagnostic précoce du syndrome de déficit en GLUT1" on YOUTUBE
Oct 17, 2018
Metafora Biosystems Youtube Channel
Metafora Biosystems posted a video "METAglut1, for the early diagnosis of the GLUT1 deficiency syndrome" on YOUTUBE
Jul 03, 2018
BioPortfolio
Metafora: Metafora Biosystems Receives 3.2 Million from European Commissions H2020 SME Instrument Program
Jun 11, 2018
360DX
Metafora: Metafora Biosystems Receives €3.2M to Develop Diagnostic for De Vivo Disease
Metafora Biosystems Competitors
1
2
3
4
5
6
7
8
9
10